Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • alunem
    Junior Member
    • Feb 2011
    • 5

    MiSeqDx specifications

    What are the specifications of the FDA-cleared version of the MiSeq. As I understood, it's a downgrade version of it (as it had to be locked since the beginning of FDA application processing), but what exactly?
    - what is the expected ouput (number of reads, lenght...)
    - what files are going to be available for the user? (are we going to have access to fastq files? bcl?)

    Well, it's not easy to find these information on illumina's website.

    Thanks!
  • alunem
    Junior Member
    • Feb 2011
    • 5

    #3
    Thanks, this answers my first question. Any idea about files available after sequencing processed?

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #4
      You may want to check with your local FAS (who can in turn check with someone here in the US, if the instrument is not available in France).

      My feeling (speculation) is the output may be some kind of a summary report saying such and such mutation is present/absent. No data may be directly accessible. Someone who has a MiSeqDX perhaps can provide additional information.

      Comment

      • NextGenSeq
        Senior Member
        • Apr 2009
        • 482

        #5
        Wonder how they dealt with the well known carryover contamination issue. This would be a major problem for viral or tumor sequencing.

        Comment

        Latest Articles

        Collapse

        • mylaser
          Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by mylaser
          Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
          If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
          This guide explains everything you need to know about...
          Today, 01:13 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-02-2026, 11:08 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Working...